HIV/AIDS: Facts, Statistics, Symptoms, Causes, Diagnosis, and Treatments

HIV has been studied for more than four decades, yet misinformation about it still travels with impressive speedand unlike HIV, myths do not need contact with specific body fluids to spread. The reality is both more serious and more hopeful: HIV remains a major public health concern, but modern testing, prevention, and treatment have transformed the outlook for people living with the virus.

Today, someone who receives an early HIV diagnosis, starts antiretroviral therapy, and remains in care can often expect a long, active life. Effective treatment can also reduce the virus to an undetectable level, preventing sexual transmission. Understanding the facts helps replace fear with practical action, whether that means getting tested, seeking emergency medication after an exposure, or supporting someone living with HIV.

What Are HIV and AIDS?

HIV stands for human immunodeficiency virus. It attacks the immune system, especially CD4 T cells, which help organize the body’s response to infections. Think of CD4 cells as immune-system coordinators: they do not handle every problem personally, but things can become chaotic when too many disappear.

HIV uses infected cells to make copies of itself. Without treatment, the viral load may rise while the CD4 count gradually falls, leaving the body increasingly vulnerable to infections and certain cancers.

AIDS stands for acquired immunodeficiency syndrome. It is the most advanced stage of HIV infection, not a separate virus. In the United States, a person with HIV may be diagnosed with AIDS when the CD4 count falls below 200 cells per cubic millimeter or when an AIDS-defining illness develops. Effective treatment can restore immune function, although an AIDS diagnosis remains part of the person’s medical history.

HIV-1 and HIV-2

HIV-1 causes the overwhelming majority of infections worldwide and in the United States. HIV-2 is less common, progresses more slowly on average, and is concentrated primarily in West Africa, although cases occur elsewhere. Testing algorithms can distinguish between the two because treatment planning may differ.

Current HIV/AIDS Statistics

Globally, an estimated 41 million people were living with HIV at the end of 2025. Approximately 1.2 million people acquired HIV that year, while about 570,000 died from HIV-related causes. These figures represent major improvement from the epidemic’s deadliest years, but they also show that HIV has not politely packed its bags and left.

In the United States, more than 1.2 million people are estimated to be living with HIV. Nearly 39,000 HIV diagnoses were reported in 2024. A diagnosis is not necessarily a newly acquired infection; someone may live with HIV for years before being tested.

More than one in five people diagnosed in 2024 already had AIDS, suggesting that many infections were found late. Viral suppression among all Americans living with HIV increased from 67% in 2023 to 69% in 2024, but significant gaps in testing, treatment access, and continued care remain.

HIV does not affect every community equally. Gay, bisexual, and other men who have sex with men remain the most affected population in U.S. surveillance data. Black and Hispanic or Latino communities also experience disproportionate rates. These differences are influenced by health care access, stigma, poverty, insurance coverage, housing instability, discrimination, and local availability of prevention servicesnot by race or identity itself.

Stages and Symptoms of HIV

Symptoms vary by stage, and many people have no obvious symptoms. No rash, fever, or internet symptom checklist can confirm HIV. Testing is the only reliable way to know.

Stage 1: Acute HIV Infection

Acute infection usually develops two to four weeks after HIV is acquired. The virus multiplies rapidly, producing a high viral load and making transmission more likely. Some people experience a flu-like illness lasting several days or weeks, while others feel completely normal.

Possible acute HIV symptoms include:

• Fever or chills
• Fatigue
• Muscle aches
• Sore throat
• Swollen lymph nodes
• Headache
• Night sweats
• Skin rash
• Mouth ulcers
• Diarrhea

These symptoms overlap with influenza, COVID-19, mononucleosis, and other infections. Feeling feverish after a possible exposure is a reason to contact a health professional, not a reason to diagnose yourself during a 2 a.m. search session.

Stage 2: Chronic HIV Infection

During chronic infection, sometimes called clinical latency, HIV remains active but may reproduce more slowly. A person can have no symptoms for years while the immune system sustains gradual damage. Without treatment, this stage commonly progresses, although the timing varies widely.

People taking effective antiretroviral therapy can remain in this stage without developing AIDS. When treatment keeps the viral load undetectable, HIV is not sexually transmitteda principle known as Undetectable Equals Untransmittable, or U=U.

Stage 3: AIDS

Advanced immune damage allows opportunistic infections and cancers to cause illness more easily. Possible signs include:

• Recurring fever or heavy night sweats
• Unexplained weight loss
• Persistent diarrhea
• Extreme fatigue
• Long-lasting swollen lymph nodes
• Persistent mouth, genital, or anal sores
• Shortness of breath or chronic cough
• White patches in the mouth caused by thrush
• Neurologic problems, including confusion or memory changes

AIDS-related illnesses may include Pneumocystis pneumonia, tuberculosis, cryptococcal meningitis, toxoplasmosis, cytomegalovirus disease, Kaposi sarcoma, and certain lymphomas. With timely HIV treatment and preventive care, these complications have become far less common.

What Causes HIV and How Is It Transmitted?

HIV transmission can occur when certain fluids from a person with a transmissible viral load reach another person’s bloodstream, damaged tissue, or mucous membranes. Relevant fluids include blood, semen, pre-seminal fluid, vaginal fluid, rectal fluid, and breast milk.

The main transmission routes are:

• Anal or vaginal sex without effective prevention, such as condoms, PrEP, or viral suppression
• Sharing needles, syringes, or other injection equipment
• Transmission during pregnancy, delivery, or breastfeeding
• Accidental occupational exposure to infected blood, although this is uncommon

Receptive anal sex carries the highest sexual transmission risk because the rectal lining is delicate and provides a potential route into the bloodstream. Untreated sexually transmitted infections may increase susceptibility by causing inflammation or sores.

Blood transfusion transmission is now extraordinarily rare in the United States because donated blood is carefully screened. Medical equipment used by licensed facilities is sterilized or discarded after use.

How HIV Does Not Spread

HIV does not spread through air, water, toilet seats, dishes, drinking glasses, casual kissing, hugging, handshakes, sweat, tears, or unbroken skin. It is not transmitted by mosquitoes or ticks. Mosquitoes may ruin a picnic, but they do not inject another person’s blood when they bite.

Saliva alone does not transmit HIV. Activities such as sharing food, living in the same home, working together, or using the same swimming pool are safe. Correcting these myths matters because unnecessary fear fuels discrimination against people living with HIV.

How HIV Is Diagnosed

Modern HIV tests are highly accurate, but no test detects infection immediately after exposure. The interval between acquisition and reliable detection is called the window period.

Antibody Tests

Antibody tests look for the immune system’s response to HIV. Most rapid and at-home HIV tests are antibody tests. They generally detect infection 23 to 90 days after exposure. A negative result obtained too early may need to be repeated.

Antigen/Antibody Tests

Fourth-generation tests detect HIV antibodies and the p24 antigen, a viral protein that appears before antibodies. A laboratory antigen/antibody test using blood from a vein can usually detect infection 18 to 45 days after exposure. Finger-stick versions may have a window period of 18 to 90 days.

Nucleic Acid Tests

A nucleic acid test, or NAT, looks directly for HIV genetic material in blood and can usually detect infection 10 to 33 days after exposure. Because NATs are relatively expensive, they are not generally used for routine screening. They may be appropriate after a recent high-risk exposure, especially when acute symptoms are present but an initial screening test is negative.

A reactive rapid or self-test is preliminary and requires follow-up testing. Laboratories typically confirm a reactive screening result with tests that distinguish HIV-1 from HIV-2; a NAT may resolve an indeterminate result or identify acute infection.

Who Should Be Tested?

The CDC recommends that everyone ages 13 to 64 receive at least one HIV test as part of routine health care. The U.S. Preventive Services Task Force recommends screening everyone ages 15 to 65, younger or older people with increased risk, and all pregnant patients. People with continuing exposure risk may benefit from annual or more frequent testing.

After an HIV diagnosis, clinicians generally order a viral load, CD4 count, drug-resistance testing, and laboratory tests assessing kidney and liver health. Screening for hepatitis, tuberculosis, sexually transmitted infections, and other conditions helps create a safe, individualized treatment plan.

HIV/AIDS Treatments

Antiretroviral Therapy

The standard treatment is antiretroviral therapy, commonly shortened to ART. It combines medications that interfere with different stages of HIV’s life cycle. Major drug classes include integrase inhibitors, nucleoside or nucleotide reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, protease inhibitors, and entry or attachment inhibitors.

Many initial regimens combine an integrase inhibitor with two reverse transcriptase inhibitors, sometimes in one daily tablet. Long-acting injections given monthly or every two months may be available for eligible patients, including some who already have stable viral suppression. The best regimen depends on resistance results, other medical conditions, pregnancy considerations, medication interactions, and patient preferences.

ART is recommended for everyone with HIV and should begin as soon as possible after diagnosis. Treatment prevents the virus from making new copies, allowing the immune system to recover. Most people who take an effective regimen consistently achieve viral suppression within several months.

What an Undetectable Viral Load Means

An undetectable result means that the amount of HIV in the blood is below the laboratory test’s detection threshold. It does not mean the virus has disappeared. HIV remains in hidden cellular reservoirs, which is why stopping medication can allow the viral load to rebound.

Extensive evidence shows that a person who takes ART and maintains an undetectable viral load has zero risk of sexually transmitting HIV. U=U is both a medical breakthrough and a powerful antidote to stigma. It does not prevent other sexually transmitted infections, and regular viral-load monitoring remains essential.

Side Effects and Drug Resistance

Modern HIV medicines are generally easier to tolerate than older treatments, but side effects can occur. Depending on the regimen, these may include nausea, headache, sleep changes, weight changes, or effects on the kidneys, liver, cholesterol, or bone health.

Missing doses repeatedly can allow HIV to multiply and develop drug resistance. However, adherence difficulties are not a character flaw. Cost, depression, unstable housing, privacy concerns, transportation, and complicated schedules can all interfere. Clinicians and care teams can simplify treatment, address side effects, connect patients with assistance programs, and choose options that fit real life.

How to Prevent HIV

• Use PrEP: Pre-exposure prophylaxis is available as pills or injections for people without HIV who may be exposed. When taken as prescribed, PrEP reduces sexual acquisition risk by about 99%. Oral PrEP reduces risk from injection drug use by at least 74%.
• Seek PEP after an exposure: Post-exposure prophylaxis is an emergency 28-day course of medication. It must begin within 72 hours, and the sooner it starts, the better.
• Use condoms correctly: Condoms reduce HIV risk and also help prevent several other sexually transmitted infections.
• Use sterile injection equipment: Never share needles, syringes, cookers, or other drug-injection supplies.
• Get tested: Knowing your status allows early treatment or helps determine whether PrEP would be useful.
• Treat HIV consistently: Maintaining an undetectable viral load prevents sexual transmission.

HIV treatment during pregnancy can reduce perinatal transmission risk to below 1% when combined with appropriate prenatal, delivery, and infant care. Feeding decisions and medication plans should be discussed with an experienced HIV and obstetric care team.

Living With HIV: Experiences Beyond the Medical Chart

HIV is measured with laboratory numbers, but living with it involves much more than viral loads and CD4 counts. The following examples reflect common themes reported by patients and care teams rather than the story of any single individual.

The First Days After Diagnosis

A new diagnosis may produce fear, disbelief, anger, or a sudden urge to reorganize one’s entire life before lunch. Some people immediately worry about dying, even though modern treatment has dramatically changed life expectancy. Others fear rejection, employment problems, medical costs, or having to disclose their status to a partner.

The first appointment can feel like being handed an unfamiliar instruction manual written entirely in acronyms: ART, CD4, PrEP, PEP, and U=U. A skilled clinician or counselor explains each term, confirms the diagnosis, evaluates overall health, and creates manageable next steps. For many people, hearing that HIV is treatable and that undetectable HIV is not sexually transmitted becomes the first moment when panic loosens its grip.

Turning Treatment Into a Routine

Starting ART can be surprisingly ordinary. A person may take one pill with breakfast, use a reminder app, and attend periodic laboratory appointments. After several months, a previously high viral load may become undetectable while the CD4 count improves. The daily medication gradually becomes as routine as brushing one’s teethalthough most toothbrushes do not come with insurance paperwork.

Real life can still complicate adherence. A night-shift worker may struggle with consistent timing. Someone sharing a home may worry that a family member will find the bottle. Another person may lose insurance or move too far from the clinic. Pharmacists, social workers, case managers, telehealth services, and patient-assistance programs can help keep treatment uninterrupted. Long-acting injectable therapy may offer another option for certain patients.

Relationships, Disclosure, and U=U

Dating after an HIV diagnosis can feel intimidating. People may rehearse a disclosure conversation repeatedly, preparing for questions or rejection. Accurate information changes that conversation. A partner who understands U=U knows that sustained viral suppression prevents sexual transmission. A partner without HIV may also choose PrEP for additional reassurance or personal control over prevention.

Disclosure laws vary by jurisdiction, so people may benefit from confidential guidance from a local health department, HIV organization, or qualified attorney. Emotional support is equally important. Peer groups allow people to talk with others who understand the experience without requiring an introductory lecture on basic biology.

Growing Older With HIV

Many people with HIV are now managing the same concerns as everyone else: careers, relationships, cholesterol, aging parents, and knees that complain about stairs. Long-term care includes monitoring cardiovascular, kidney, liver, bone, and mental health. Smoking cessation, exercise, recommended vaccinations, nutritious food, and routine cancer screening remain important.

Some individuals continue to face stigma in health care, workplaces, or families. Others become advocates, mentors, parents, or community educators. No single “HIV experience” exists. A person’s quality of life is shaped not only by medication but also by safe housing, supportive relationships, reliable health care, cultural understanding, and freedom from discrimination.

From Surviving to Planning a Future

One of the most meaningful changes after successful treatment is the return of ordinary planning. People make travel reservations, pursue promotions, start relationships, and discuss having children. The future stops looking like a medical emergency and begins looking like a calendar again.

That shift does not erase difficult days, but it demonstrates why early testing and continuous care matter. HIV may remain part of a person’s life, yet it does not have to become the headline of every chapter.

Conclusion

HIV attacks the immune system and can progress to AIDS when untreated, but that progression is preventable. Modern HIV testing can identify infection early, ART can suppress the virus, and U=U prevents sexual transmission. PrEP, PEP, condoms, sterile injection supplies, and routine screening provide highly effective prevention options.

The most useful response to HIV is neither panic nor judgment. It is timely testing, accurate information, compassionate care, and treatment that fits the realities of a person’s life.